Caplight Directory>Investors>Flerie Invest>Flerie-invest-1


Flerie Invest

Flerie Invest

Stockholmflerie.com

Overview

Flerie Invest is a publicly traded, long-term global venture capital firm that invests in early-stage and growth-stage companies in the life science, biotech, and pharma sectors. Based in Stockholm, Sweden, and London, United Kingdom, the firm manages a portfolio of companies across Europe, Israel, and the US. Flerie operates through three segments: Product Development, Commercial Growth, and Limited Partnerships, where it also invests in other funds.

Year Founded

2011

Portfolio Companies

11

Website

flerie.com

Investments

CompanyDateStageLead
NumabJan 2025Series C Extension-
ProkariumFeb 2023Series CCo-investor
Inversago PharmaOct 2022Series C-
Geneos TherapeuticsMar 2022Series A ExtensionLead
MicrobioticaMar 2022Series BLead
View all investments

Key People

Michaela Gertz

Chief Financial Officer

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersStockholm
Year Founded2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.